Ikapharmindo Putramas Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp199 (market cap 330.19B, 215.9K 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp109 (market cap 608.51B, 16.35M 24h volume). The key difference: Saraswanti Indoland Development Tbk. is the larger of the two by market cap, and Saraswanti Indoland Development Tbk. is more actively traded (16.35M versus 215.9K). Which is the better fit depends on your goals.
| IKPM | SWID | |
|---|---|---|
Market Cap | 330.19B | 608.51B |
Volume | 215.9K | 16.35M |
Lot | 2.16K | 163.51K |
Turnover | 42.44M | 1.79B |
Average Price | 196.56 | 109.4 |
Value | 42.44M | 1.79B |
Indicative Equilibrium Price | 199 | 109 |
Indicative Equilibrium Volume | 9 | 9.34K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →